Stockholm, Sweden

Johan Grunewald

This inventor holds 1 USPTO granted patent. Top assignee: Avant Immunotherapeutics, Inc.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Johan Grunewald

Introduction

Johan Grunewald is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of medical research, particularly in the therapy of sarcoidosis. His work has led to the development of innovative solutions that aim to improve patient outcomes.

Latest Patents

Johan Grunewald holds a patent for a therapy specifically targeting sarcoidosis. This patent represents his commitment to advancing medical treatments and showcases his innovative approach to addressing complex health issues. He has 1 patent to his name, reflecting his dedication to research and development in the medical field.

Career Highlights

Grunewald is associated with Avant Immunotherapeutics, Inc., a company focused on developing novel immunotherapies. His role at the company has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical science.

Collaborations

Some of his notable coworkers include Hans Wigzell and Carl Harald Janson. Their collaboration has fostered an environment of innovation and shared knowledge, which is essential for advancing research in immunotherapy.

Conclusion

Johan Grunewald's work exemplifies the spirit of innovation in the medical field. His contributions, particularly in the therapy of sarcoidosis, highlight the importance of research and collaboration in developing effective treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…